Although further safety data is needed, endoscopic ultrasound may prove to be an effective way of administering localized chemotherapy.
Obesity not only increases risk for diabetes and cardiovascular diseases; it can also be a risk factor for many types of cancer.
Two recent studies demonstrate that microwave ablation offers rapid pain relief with few complications.
Women who have a 3% or greater 5-year risk for breast cancer may benefit from primary prevention with tamoxifen or raloxifene.
Researchers from UCLA School of Public Health found that exposure to air pollution in utero and during the first year of life raises the risk for certain childhood cancers.
Lymphoseek has now demonstrated significant efficacy in diagnosis and staging of squamous cell carcinoma of the head and neck.
A new phase 3 trial has found adding cetuximab to chemo for patients with unresectable colorectal liver mets extends survival, but more research is needed to develop more targeted therapies.
Better treatment for hospitalized patients with infections may have reduced their risk of dying, but racial and economic disparities in infection rates persist.
New tests are on the market or in development, but predicting outcomes for prostate cancer patients is still an uncertain science.
An update to the Children's Oncology Group guidelines provides recommendations for monitoring reproductive and sexual health in female survivors of childhood, adolescent, and young adult cancer.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|